Inventor
KRUSE THOMAS
DK61 patents
⚠️ This page may combine multiple inventors who share the name “KRUSE THOMAS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NOVO NORDISK AS
21 patentsUS10005827B2Jun 26, 2018
Double-acylated GLP-1 derivatives
NOVO NORDISK AS24 citations94
US11117947B2Sep 14, 2021
Double-acylated GLP-1 derivatives
NOVO NORDISK AS7 citations83
US11034746B2Jun 15, 2021
Double-acylated GLP-1 derivatives
NOVO NORDISK AS6 citations83
US9409966B2Aug 9, 2016
Glucagon-like peptide-1 derivatives and their pharmaceutical use
NOVO NORDISK AS6 citations83
US9067977B2Jun 30, 2015
Peptides derivatized with A-B-C-D- and their therapeutical use
NOVO NORDISK AS18 citations83
US9023789B2May 5, 2015
Amylin analogs and pharmaceutical compositions thereof
NOVO NORDISK AS11 citations82
US8541368B2Sep 24, 2013
Glucagon analogues
NOVO NORDISK AS6 citations82
US9593149B2Mar 14, 2017
Amylin and calcitonin receptor agonist
NOVO NORDISK AS3 citations70
US11186595B2Nov 30, 2021
Glucose-sensitive albumin-binding derivatives
NOVO NORDISK AS3 citations68
US9029325B2May 12, 2015
Amylin analogues and pharmaceutical compositions thereof
NOVO NORDISK AS2 citations62
US9486505B2Nov 8, 2016
Glucagon analogues
NOVO NORDISK AS2 citations61
US9486506B2Nov 8, 2016
Glucagon analogues
NOVO NORDISK AS1 citations61
US8575091B1Nov 5, 2013
Amylin analogues and pharmaceutical compositions thereof
NOVO NORDISK AS4 citations60
US11767332B2Sep 26, 2023
Glucose-sensitive albumin-binding derivatives
NOVO NORDISK AS1 citations58
US12227528B2Feb 18, 2025
Glucose-sensitive albumin-binding derivatives
NOVO NORDISK AS0 citations57
US12116388B2Oct 15, 2024
Amylin receptor agonists
NOVO NORDISK AS0 citations56
US12054528B2Aug 6, 2024
Co-agonists of the GLP-1 and amylin receptors
NOVO NORDISK AS0 citations52
US9751927B2Sep 5, 2017
Stable, protracted GLP-1/glucagon receptor co-agonists for medical use
NOVO NORDISK AS0 citations51
US9474790B2Oct 25, 2016
Stable, protracted GLP-1/glucagon receptor co-agonists for medical use
NOVO NORDISK AS0 citations51
US10174082B2Jan 8, 2019
Amylin and calcitonin receptor agonist
NOVO NORDISK AS0 citations49
US9988430B2Jun 5, 2018
Stable GLP-1 based GLP-1/glucagon receptor co-agonists
NOVO NORDISK AS1 citations49
HOVEROUND CORP
3 patentsSCHAEFFER LAUGE
3 patentsUNIFY GMBH & CO KG
3 patentsKJAER TANJA MARIA ROSENKILDE
3 patentsUS8802621B2Aug 12, 2014
Treatment of inflammatory bowel diseases with mammal beta defensins
KJAER TANJA MARIA ROSENKILDE4 citations81
US8232242B2Jul 31, 2012
Treatment of inflammatory bowel diseases with mammal beta defensins
KJAER TANJA MARIA ROSENKILDE6 citations81
US8232248B2Jul 31, 2012
Treatment of rheumatoid arthritis with mammal beta defensins
KJAER TANJA MARIA ROSENKILDE6 citations81
DOERKEN EWALD AG
2 patentsAIRBUS DEFENCE & SPACE GMBH
2 patentsUS12486049B2Dec 2, 2025
Display apparatus and method for monitoring the structural integrity of a repair location
AIRBUS DEFENCE & SPACE GMBH0 citations54
US10732066B2Aug 4, 2020
Component device and method for detecting damage in a bonding adhesive of the component device
AIRBUS DEFENCE & SPACE GMBH0 citations50
KOFOED JACOB
1 patentSPETZLER JANE
1 patentMADSEN ALICE RAVN
1 patentDEFENSIN THERAPEUTICS APS
1 patentSCHÄFFER LAUGE
1 patentSIEMENS GAMESA RENEWABLE ENERGY AS
1 patentSTREICHERT FELIX
1 patentNIELSEN ANETTE SAMS
1 patentLAU JESPER FAERGEMAN
1 patentSCHIMMLER MARC
1 patentBOSCH GMBH ROBERT
1 patentZIYLO LTD
1 patentHOEGENHAUG HANS-HENRIK KRISTENSEN
1 patentShowing the top 50 of 61 patents by PatentIndex Score.